Leef Brands (LEEEF) Short term Debt (2024 - 2026)

Leef Brands (LEEEF) reported Short term Debt of $105000.0 for Q1 2026, down 69.12% sequentially from $340000.0 in Q4 2025.

Leef Brands (LEEEF) Short term Debt (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Short term Debt data on file, last reported at $105000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Short term Debt changed N/A year-over-year to $105000.0; the trailing twelve-month figure through Mar 2026 stood at $105000.0 (changed N/A YoY), and the FY2025 full-year result was $340000.0, down 32.0% from the prior year.
  • Short term Debt fell to $105000.0 in Q1 2026, from $340000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $500000.0 in Q4 2024 to a low of $105000.0 in Q1 2026.
  • A 3-year average of $315000.0 and a median of $340000.0 in 2025 frame the typical range for Short term Debt.
  • Peak annual rise in Short term Debt reached 32.0% in 2025, while the deepest fall reached 32.0% in 2025.
  • Tracing LEEEF's Short term Debt over 3 years: stood at $500000.0 in 2024, then tumbled by 32.0% to $340000.0 in 2025, then plunged by 69.12% to $105000.0 in 2026.
  • Business Quant data shows LEEEF's Short term Debt at $105000.0 in Q1 2026, $340000.0 in Q4 2025, and $500000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 105,000.00
Dec 31, 2025 340,000.00
Dec 31, 2024 500,000.00